The PK-Eye™ can also be used with other in vitro or computational permeability models to develop in vitro in vivo correlations (IVIVCs) for small molecular weight drugs that eliminate via the retina-choroid-sclera (RCS) pathway. This is analogous to strategies that are used to develop new dosage forms for oral and pulmonary administration.